Atlas Trials

Zibotentan and Dapagliflozin in Patients With Type 2 Diabetes and Elevated Albuminuria

Clinical trial NCT05570305 · COMPLETED

Trial details

NCT number
NCT05570305
Sponsor
University Medical Center Groningen
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Kidney Diseases
Start date
2022-10-06
Primary completion
2025-03-05
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.